Clinical Trial Update: A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) [Phase 4]

View source ↗

Summary

A Phase 4 study conducted by Massachusetts General Hospital evaluating 6(S)-5-MTHF as an add-on to SSRIs in SSRI-resistant major depressive disorder has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• 6(S)-5-MTHF (L-methylfolate (5-MTHF))

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED